Aptose Biosciences Inc. (NASDAQ: APTO) Stock Information | RedChip

Aptose Biosciences Inc. (NASDAQ: APTO) Listen to this Section


$0.48
-0.0010 ( -0.21% ) 51.4K

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

Market Data


Open


$0.48

Previous close


$0.48

Volume


51.4K

Market cap


$8.77M

Day range


$0.48 - $0.52

52 week range


$0.40 - $5.10

Insider Ownership Transactions

Total Amount Purchased: -135,998.00 | $ -65,279.04

Date Type Amount Purchased Purchaser
2024-05-10 Sale 0.00 LEDRU PHILIPPE
2024-02-07 Sale -35000.00 Bejar Rafael
2024-02-07 Sale -11000.00 LEDRU PHILIPPE
2024-02-07 Sale -70000.00 Rice William G.
2024-02-07 Sale -3333.00 Seizinger Bernd R.
2024-02-07 Sale -3333.00 PLATZER ERICH
2024-02-07 Sale -3333.00 Vincent Mark D.
2024-02-07 Sale -3333.00 Ashe Carol Gail
2024-02-07 Sale -3333.00 BURGER DENIS R
2024-02-07 Sale -3333.00 Whitehead Warren

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Aug 08, 2024
10-q Quarterly Reports 61 Aug 08, 2024
8-k 8K-related 35 Jul 26, 2024
8-k 8K-related 15 Jul 19, 2024
def Proxies and info statements 13 Jul 17, 2024
pre Proxies and info statements 13 Jul 05, 2024
8-k 8K-related 15 Jun 20, 2024
8-k 8K-related 14 Jun 20, 2024
8-k 8K-related 15 Jun 14, 2024
8-k 8K-related 22 Jun 03, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.